POWER OVER AHP GLOBAL PERSPECTIVES ON LIVING WITH ACUTE HEPATIC PORPHYRIA
Live / Applied — Statement of use — processing complete, to examiner (as of 05 Sept 2025)
What this means for you
Not registered yet, but its 19 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97081007
- Mark type
- Design + words
- Filed
- 19 Oct 2021
- Published for opposition
- 22 Mar 2022
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness about porphyria among affected individuals and their families
- Class 041 — Education and entertainment services: Educational services, namely, providing education information for training medical professionals and patients regarding porphyria
- Class 044 — Medical, beauty and agricultural services: Providing medical information about porphyria
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 05 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Apr 2025 — USE AMENDMENT FILED
- 05 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2024 — SOU EXTENSION 5 GRANTED
- 08 Oct 2024 — SOU EXTENSION 5 FILED
- 08 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jul 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Jul 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2024 — SOU EXTENSION 4 GRANTED
- 16 May 2024 — SOU EXTENSION 4 FILED
- 16 May 2024 — SOU TEAS EXTENSION RECEIVED